Optic NeuritisSymptoms, Doctors, Treatments, Advances & More
Learn About Optic Neuritis
The optic nerve carries images of what the eye sees to the brain. When this nerve become swollen or inflamed, it is called optic neuritis. It may cause sudden, reduced vision in the affected eye.
Retro-bulbar neuritis; Multiple sclerosis - optic neuritis; Optic nerve - optic neuritis
The exact cause of optic neuritis is unknown.
The optic nerve carries visual information from your eye to the brain. The nerve can swell when it becomes inflamed. The swelling can damage nerve fibers. This can cause short or long-term loss of vision.
Conditions that have been linked with optic neuritis include:
- Autoimmune diseases, including lupus, sarcoidosis, and Behçet disease
- Cryptococcosis, a fungal infection
- Bacterial infections, including tuberculosis, syphilis, Lyme disease, and meningitis
- Viral infections, including viral encephalitis, measles, rubella, chickenpox, herpes zoster, mumps, and mononucleosis
- Respiratory infections, including mycoplasma pneumonia and other common upper respiratory tract infections
- Multiple sclerosis
Symptoms may include:
- Loss of vision in one eye over an hour or a few hours
- Changes in the way the pupil reacts to bright light
- Loss of color vision
- Pain when you move your eye
Vision often returns to normal within 2 to 3 weeks with no treatment.
Corticosteroids given through a vein (IV) or taken by mouth (oral) may speed up recovery. However, the final vision is no better with steroids than without. Oral steroids may actually increase the chance of recurrence.
If tests suggest that there is also multiple sclerosis, other types of treatment may be helpful.
Further tests may be needed to try to find the cause of the neuritis. If there is a condition causing the problem, it may be able to be treated.
Johns Hopkins Outpatient Center
Elias Sotirchos, M.D., specializes in the diagnosis, management and treatment of neuroimmunological disorders that involve the central nervous system, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). His research focuses on developing and validating novel imaging and blood-based biomarkers of these conditions, and clinical trials of experimental therapeutic agents. Dr. Sotirchos earned his medical degree from the National and Kapodistrian University of Athens and subsequently completed his internship and neurology residency training at The Johns Hopkins Hospital. He then pursued advanced clinical and research training in neuroimmunology at Johns Hopkins as a National MS Society Sylvia Lawry Fellow. Dr. Sotirchos is rated as an Elite provider by MediFind in the treatment of Optic Neuritis. His top areas of expertise are Optic Neuritis, Multiple Sclerosis (MS), Neuromyelitis Optica, and Transverse Myelitis.
St. Vincent Neurosurgery
Dr. French is an investigator involved in clinical research trials in the area of neurology. His clinical research focus includes Multiple Sclerosis, migraines and headaches. Dr. French is rated as a Distinguished provider by MediFind in the treatment of Optic Neuritis. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Optic Neuritis, and Migraine.
Johns Hopkins University
Peter Calabresi is a Neurologist in Baltimore, Maryland. Dr. Calabresi is rated as an Elite provider by MediFind in the treatment of Optic Neuritis. His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome.
When optic neuritis occurs without other diseases, there is a better prognosis. An MRI is an important test because it can help predict if multiple sclerosis or other similar autoimmune diseases are present or may develop.
Optic neuritis caused by multiple sclerosis or other autoimmune diseases has a poorer outlook. However, vision in the affected eye may still return to normal.
Complications may include:
- Body-wide side effects from corticosteroids
- Vision loss
Some people who have an episode of optic neuritis will develop nerve problems in other places in the body or develop multiple sclerosis.
Contact your health care provider right away if you have a sudden loss of vision in one eye, especially if you have eye pain.
If you have been diagnosed with optic neuritis, contact your provider if:
- Your vision decreases.
- The pain in the eye gets worse.
- Your symptoms do not improve within 2 to 3 weeks.
Summary: The primary objective of this study is to describe the frequency and characteristics of pregnancy outcomes and maternal complications among participants exposed to Ultomiris and to describe the frequency and characteristics of selected fetal/neonatal/infant outcomes in utero, at birth, and through 1 year of age after exposure in utero or via breastmilk.
Summary: Long-term, multicenter, multinational, observational, registry of patients with AQP4+ NMOSD that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT). The registry will also collect data on patient reported outcomes (PROs), quality of life (QoL), and targeted AQP4+ NMOSD therapies used to provide evidence on the real-world impact ...
Published Date: January 29, 2024
Published By: Audrey Tai, DO, MS, Athena Eye Care, Mission Viejo, CA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Bennett JL. Optic neuritis. Continuum (Minneap Minn). 2019;25(5):1236-1264. PMID: 31584536 pubmed.ncbi.nlm.nih.gov/31584536/.
Calabresi PA. Multiple sclerosis and demyelinating conditions of the central nervous system. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 380.
Filipi M, Jack S. Interferons in the treatment of multiple sclerosis: a clinical efficacy, safety, and tolerability update. Int JMS Care. 2020;22(4):165-172. PMID: 32863784 pubmed.ncbi.nlm.nih.gov/32863784/.
Moss HE, Balcer LJ. Inflammatory optic neuropathies and neuroretinitis. In: Yanoff M, Duker JS, eds. Ophthalmology. 6th ed. Philadelphia, PA: Elsevier; 2023:chap 9.7.
Thurtell MJ, Prasad S, Tomsak RL. Neuro-ophthalmology: afferent visual system. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 16.